Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice

Circulation

Volumn 110, Issue 11, 2004, Pages 1492-1498

  Boord, Jeffrey B ^a,c   Maeda, Kazuhisa ^b,e   Makowski, Liza ^b   Babaev, Vladimir R ^c   Fazio, Sergio ^c   Linton, MacRae F ^c,d   Hotamisligil, Gökhan S ^b  

^a GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Macrophages; Metabolism; Syndrome X

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; FATTY ACID BINDING PROTEIN; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE TOLERANCE; HYPERLIPOPROTEINEMIA TYPE 3; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; LIPID METABOLISM; LOW FAT DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; AORTA; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOOD GLUCOSE; CARRIER PROTEINS; CHOLESTEROL; DIET, FAT-RESTRICTED; FATTY ACID-BINDING PROTEINS; FEMALE; HYPERLIPOPROTEINEMIA TYPE II; INSULIN RESISTANCE; LONGEVITY; MALE; MESENTERY; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; ORGAN SIZE; TRIGLYCERIDES;

EID: 4544298808     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000141735.13202.B6     Document Type: Article

References (32)

1. Reusch JEB. Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. Am J Cardiol. 2002;90:19-26.
2. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
3. Hotamisligil GS, Johnson RS, Distel RJ. et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274:1377-1379.
4. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001;7:699-705.
5. Boord JB, Maeda K, Makowski L, et al. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2002;22:1686-1691.
6. Boord JB, Fazio S, Linton MF. Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol. 2002;13:141-147.
7. Spiegelman BM, Frank M, Green H. Molecular cloning of mRNA from 3T3 adipocytes: regulation of mRNA content for glycerolphosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. J Biol Chem. 1983;258:10083-10089.
8. Hunt CR, Ro JH, Dobson DE, et al. Adipocyte P2 gene: developmental expression and homology of 5′-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci U S A. 1986;83:3786-3790.
9. Fu Y, Luo N, Lopes-Virella MF. Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res. 2000;41:2017-2023.
10. Distel RJ, Robinson GS, Spiegelman BM. Fatty acid regulation of gene expression: transcriptional and post-transcriptional mechanisms. J Biol Chem. 1992;267:5937-5941.
11. Pelton PD, Zhou L, Demarest KT, et al. PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun. 1999;261:456-458.
12. Fu Y, Luo N, Lopes-Virella MF, et al. The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis. 2002;165:259-269.
13. Krieg P, Feil S, Fürstenberger G, et al. Tumor specific overexpression of a novel keratinocyte lipid binding protein. J Biol Chem. 1993;23: 17362-17369.
14. Uysal KT, Scheja L, Wiesbrock SM, et al. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology. 2000; 141:3388-3396.
15. Maeda K, Uysal KT, Makowski L, et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes. 2003;52: 300-307.
16. Fazio S, Hasty AH, Carter KJ, et al. Leukocyte low density lipoprotein receptor (LDL-R) does not contribute to LDL clearance in vivo: bone marrow transplantation studies in the mouse. J Lipid Res. 1997;38:391-400.
17. Babaev VR, Fazio S, Gleaves LA, et al. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J Clin Invest. 1999;103:1697-1705.
18. Uysal KT, Wiesbrock SM, Hotamisligil GS. Functional analysis of TNF receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology. 1998;139:4832-4838.
19. Babaev VR, Patel MB, Semenkovich CF, et al. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice. J Biol Chem. 2000:275: 26293-26299.
20. Fazio S, Babaev VR, Burleigh ME, et al. Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice. J Lipid Res. 2002;43:1602-1609.
21. Paigen B, Morrow A, Holmes PA, et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68:231-240.
22. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999;274:19055-19062.
23. -/- mice. Diabetes. 1999; 48:1987-1994.
24. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocrinol Rev. 2000;21:697-738.
25. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-946.
26. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996;221: 286-289.
27. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis. 2001;154:399-406.
28. Calara F, Silvestre M, Casanada F, et al. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol. 2001;195:257-263.
29. Williams H, Johnson JL, Carson KG, et al. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002;22: 788-792.
30. Cyrus T, Sung S, Zhao L, et al. Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation. 2002;106:1282-1287.
31. Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci USA. 2000;97:7458-7463.
32. Palinski W, Napoli C. Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol. 2002:22:1745-1750.